Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2023

Oct 16, 2023

5250_mrq_2023-10-16_7f9d159c-8a27-4bc5-afb7-e780c0d5c6fc.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2564Q

Barclays PLC

16 October 2023

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose DECHRA PHARMACEUTICALS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 13 Oct 2023
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: 1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 7,455,358 6.55% 1,987,172 1.74%
(2) Cash-settled derivatives:
and/or controlled: 1,316,856 1.16% 7,364,916 6.47%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 8,772,214 7.70% 9,352,088 8.21%
(b) Rights to subscribe for new securities (including directors and other executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
1p ordinary Purchase 69,861 37.9209  GBP
1p ordinary Purchase 16,651 37.9148  GBP
1p ordinary Purchase 15,436 37.9601  GBP
1p ordinary Purchase 14,988 37.9408  GBP
1p ordinary Purchase 6,792 37.9200  GBP
1p ordinary Purchase 3,504 37.9400  GBP
1p ordinary Purchase 2,156 37.9607  GBP
1p ordinary Purchase 1,690 37.9662  GBP
1p ordinary Purchase 709 37.9647  GBP
1p ordinary Purchase 605 37.9600  GBP
1p ordinary Purchase 413 37.9792  GBP
1p ordinary Purchase 260 37.9257  GBP
1p ordinary Purchase 88 37.9700  GBP
1p ordinary Sale 73,213 37.9200  GBP
1p ordinary Sale 47,841 37.9310  GBP
1p ordinary Sale 25,000 37.9225  GBP
1p ordinary Sale 11,555 37.9400  GBP
1p ordinary Sale 9,029 37.9323  GBP
1p ordinary Sale 2,932 37.9243  GBP
1p ordinary Sale 2,524 37.9362  GBP
1p ordinary Sale 826 37.9433  GBP
1p ordinary Sale 560 37.9600  GBP
1p ordinary Sale 400 37.9389  GBP
1p ordinary Sale 269 37.9324  GBP
1p ordinary Sale 245 37.8844  GBP
1p ordinary Sale 30 37.9300  GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
1p ordinary CFD Long 110 37.9400  GBP
1p ordinary SWAP Long 381 37.9600  GBP
1p ordinary SWAP Long 1,325 37.9315  GBP
1p ordinary SWAP Long 2,524 37.9362  GBP
1p ordinary SWAP Long 24,614 37.9319  GBP
1p ordinary SWAP Long 25,000 37.9225  GBP
1p ordinary SWAP Long 34,108 37.9298  GBP
1p ordinary SWAP Short 115 37.9800  GBP
1p ordinary SWAP Short 303 37.9433  GBP
1p ordinary CFD Short 452 37.9651  GBP
1p ordinary SWAP Short 454 37.9318  GBP
1p ordinary SWAP Short 529 37.9730  GBP
1p ordinary SWAP Short 1,028 37.9600  GBP
1p ordinary CFD Short 1,690 37.9662  GBP
1p ordinary CFD Short 2,568 37.9564  GBP
1p ordinary SWAP Short 14,627 37.9620  GBP
1p ordinary SWAP Short 14,988 37.9408  GBP
1p ordinary SWAP Short 16,651 37.9148  GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 Oct 2023
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEAEEKFLPDFFA